Bicycle Therapeutics plc
BCYC
$4.01
-$0.18-4.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -50.33M | -60.83M | -20.15M | -59.10M | -78.95M |
| Total Depreciation and Amortization | 1.07M | 1.13M | 1.34M | 1.76M | 1.70M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.73M | 6.69M | 12.50M | 8.73M | 9.10M |
| Change in Net Operating Assets | -7.07M | -12.92M | -13.02M | -22.55M | -4.63M |
| Cash from Operations | -49.61M | -65.93M | -19.35M | -71.17M | -72.79M |
| Capital Expenditure | -265.00K | -713.00K | -574.00K | -674.00K | -498.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -265.00K | -713.00K | -574.00K | -674.00K | -498.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -51.00K | -66.00K | -48.00K | -31.00K | -46.00K |
| Issuance of Common Stock | 1.00K | 12.00K | 33.00K | 1.00K | 1.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -50.00K | -54.00K | -15.00K | -30.00K | -45.00K |
| Foreign Exchange rate Adjustments | -49.00K | -1.94M | -222.00K | -1.25M | 1.81M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -49.97M | -68.64M | -20.16M | -73.13M | -71.52M |